Valsartan cas: 137862-53-4

CAS NO: 137862-53-4
Valsartan
Description Review
Description

Valsartan is a medication used to treat high blood pressure, heart failure, and other heart-related conditions. It is an angiotensin receptor blocker (ARB) that relaxes blood vessels, allowing blood to flow more easily. Valsartan was first approved for use in the United States in 1996 and is now widely prescribed around the world. Its chemical name is N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine and it has a molecular formula of C24H29N5O3.

Chemical Name:

The chemical name of Valsartan is N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine.

Molecular Formula:

The molecular formula of Valsartan is C24H29N5O3.

Formula Weight:

The formula weight of Valsartan is 435.52 g/mol.

CAS No:

The CAS number for Valsartan is 137862-53-4.

Top Ten Keywords from Google and Synonyms:

  1. High Blood Pressure: hypertension, HBP
  2. Heart Failure: congestive heart failure, CHF
  3. Angiotensin Receptor Blocker: ARB, Losartan, Irbesartan
  4. Blood Vessels: veins, arteries
  5. Antihypertensive: blood pressure-lowering, blood pressure medication
  6. Cardiovascular Disease: heart disease, stroke
  7. Renal Impairment: kidney disease, renal dysfunction
  8. Hypertensive Emergency: severe hypertension, hypertensive crisis
  9. Chronic Heart Failure: long-term heart failure, chronic cardiac insufficiency
  10. Myocardial Infarction: heart attack, MI

Health Benefits of this Product:

Valsartan is primarily used to treat high blood pressure (hypertension) and heart failure. By blocking the action of angiotensin II, a hormone that causes blood vessels to constrict, Valsartan helps to lower blood pressure and improve blood flow to the heart. This can reduce the risk of heart attack, stroke, and other cardiovascular complications.

Potential Effects:

Valsartan has been shown to effectively lower blood pressure in clinical studies. It may also have additional benefits for people with heart failure, as it can improve symptoms and reduce the risk of hospitalization. In some cases, Valsartan may be used in combination with other medications, such as diuretics or beta-blockers, to achieve better blood pressure control and further reduce the risk of cardiovascular events.

Product Mechanism:

Valsartan works by blocking the action of angiotensin II, a hormone that constricts blood vessels and increases blood pressure. By blocking the receptors that normally bind to angiotensin II, Valsartan allows blood vessels to relax and widen, improving blood flow and reducing blood pressure. This mechanism of action makes Valsartan an effective antihypertensive medication that can help reduce the risk of cardiovascular disease.

Safety:

Valsartan is generally safe when used as directed by a healthcare provider. Most people who take Valsartan do not experience any significant side effects. However, like all medications, Valsartan can cause allergic reactions, including swelling of the face, lips, tongue, or throat, difficulty breathing, and hives. If you experience these symptoms, seek medical attention immediately.

Side Effects:

Some common side effects of Valsartan include dizziness, lightheadedness, headache, fatigue, and diarrhea. Less common side effects may include muscle weakness, joint pain, back pain, and dry mouth. In rare cases, Valsartan may cause more serious side effects, such as kidney problems or liver damage. If you experience any unusual symptoms while taking Valsartan, speak with your healthcare provider.

Dosing Information:

The recommended starting dose of Valsartan for adults with hypertension is typically 80 mg per day, taken once daily. This dosage may be increased to a maximum of 320 mg per day, depending on individual response and tolerance. For heart failure, the recommended starting dose is typically 40 mg twice daily, with a maximum dosage of 160 mg twice daily.

Conclusion:

Overall, Valsartan is an effective medication that can help lower blood pressure and reduce the risk of cardiovascular disease. It is generally safe when used as directed, although some people may experience side effects. By blocking the action of angiotensin II, Valsartan allows blood vessels to relax and widen, improving blood flow and reducing blood pressure.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code